1. The cisplatin-based Pt(iv)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions
   Elisabetta Gabano et al, 2018, Dalton Transactions CrossRef
2. hif-1plays a role in hypoxia-induced gustatory plasticity ofCaenorhabditis elegans
   Nabila Sorathia et al, 2019, International Journal of Neuroscience CrossRef
3. Transcutaneous Carbon Dioxide Decreases Immunosuppressive Factors in Squamous Cell Carcinoma In Vivo
   Nanae Yatagai et al, 2021, BioMed Research International CrossRef
4. Seizures and gliomas — towards a single therapeutic approach
   Gilles Huberfeld et al, 2016, Nature Reviews Neurology CrossRef
5. Las propiedades epigenéticas y anticáncer del ácido valproico
   Ismael Vásquez-Moctezuma et al, 2020, Revista Mexicana de Mastología CrossRef
6. VPA does not enhance platinum binding to DNA in cisplatin-resistant neuroblastoma cancer cells
   Martina Raudenska et al, 2017, Tumor Biology CrossRef
7. Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1
   Helena Doktorova et al, 2015, Biomedical Papers CrossRef
8. Hypoxia signalling and regulation in chemosensory behaviour of Caenorhabditis elegans
   G. Macnee et al, 2015, Bioscience Horizons CrossRef
9. Perftoran® Inhibits Hypoxia-Associated Resistance in Lung Cancer Cells to Carboplatin
   Amira M. Gamal-Eldeen et al, 2022, Frontiers in Pharmacology CrossRef
10. Pathogenesis and therapeutic strategy in platinum resistance lung cancer
    Panpan Lv et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
11. The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells
    TOMAS GROH et al, 2015, International Journal of Oncology CrossRef
12. Valproic Acid Induces the Hyperacetylation of P53, Expression of P53 Target Genes, and Markers of the Intrinsic Apoptotic Pathway in Midorganogenesis Murine Limbs
    France‐Hélène Paradis et al, 2015, Birth Defects Research Part B: Developmental and Reproductive Toxicology CrossRef
13. Histone Deacetylase Inhibitors as Anticancer Drugs
    Tomas Eckschlager et al, 2017, International Journal of Molecular Sciences CrossRef
14. Delivery of siRNA targeting HIF-1α loaded chitosan modifiedd-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) nanoparticles into nasopharyngeal carcinoma cell to improve the therapeutic efficacy of cisplatin
    Daizheng Lian et al, 2016, RSC Advances CrossRef
15. Alterations of histone modifications in cancer
    Maha M. Saber-Ayad et al, 2024, Epigenetics in Human Disease CrossRef
16. 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts
    Raoud Marayati et al, 2021, Translational Oncology CrossRef
17. Activation of AMP-Activated Protein Kinase α and Extracelluar Signal-Regulated Kinase Mediates CB-PIC-Induced Apoptosis in Hypoxic SW620 Colorectal Cancer Cells
    Sung-Yun Cho et al, 2013, Evidence-Based Complementary and Alternative Medicine CrossRef
18. The Effect of Sodium Valproate on the Glioblastoma U87 Cell Line Tumor Development on the Chicken Embryo Chorioallantoic Membrane and on EZH2 and p53 Expression
    Dovilė Kavaliauskaitė et al, 2017, BioMed Research International CrossRef
19. The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells
    Tereza Cerna et al, 2018, International Journal of Molecular Sciences CrossRef